Sagespring Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.06M Buy
10,690
+163
+2% +$82.1K 0.09% 111
2025
Q4
$4.91M Buy
10,527
+426
+4% +$198K 0.09% 111
2025
Q3
$4.31M Sell
10,101
-39
-0.4% -$15.1K 0.08% 116
2025
Q2
$3.88M Buy
10,140
+769
+8% +$277K 0.08% 121
2025
Q1
$3.24M Buy
9,371
+522
+6% +$168K 0.08% 117
2024
Q4
$2.66M Buy
+8,849
New +$3.09M 0.07% 118

Other funds holding HCA

Sagespring Wealth Partners's HCA Position: Q1 2026 in Review

Sagespring Wealth Partners increased its HCA Healthcare (HCA) stake by 1.5% in Q1 2026, buying an estimated $82.1K and bringing the position to 10,690 shares worth $5.06M. The position accounts for 0.09% of the portfolio, ranked #111.

Sagespring Wealth Partners first reported a position in HCA in Q4 2024 and has held it in 6 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Sagespring Wealth Partners held 10,690 shares of HCA Healthcare worth $5.06M as of Q1 2026.
  • Sagespring Wealth Partners bought 163 HCA Healthcare shares in Q1 2026, an estimated $82.1K.
  • HCA Healthcare made up 0.09% of Sagespring Wealth Partners's portfolio in Q1 2026, its #111 holding.
  • Sagespring Wealth Partners first reported a position in HCA Healthcare in Q4 2024 and has held it in 6 quarters since.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.